312
Views
2
CrossRef citations to date
0
Altmetric
Review

Managing Chronic Rhinosinusitis with Nasal Polyps in the Elderly: Challenges and Solutions

&
Pages 685-698 | Published online: 02 May 2022

References

  • Ortman JM, Velkoff VA, Hogan H. An aging nation: the older population in the United States; 2014. Available from: http://usd-apps.usd.edu/coglab/schieber/psyc423/pdf/AgingNation.pdf. Accessed January 17, 2022.
  • Yancey KL, Lowery AS, Chandra RK, Chowdhury NI, Turner JH. Advanced age adversely affects chronic rhinosinusitis surgical outcomes. Int Forum Allergy Rhinol. 2019;9(10):1125–1134. doi:10.1002/alr.22404
  • Valdés CJ, Tewfik MA. Rhinosinusitis and allergies in elderly patients. Clin Geriatr Med. 2018;34(2):217–231. doi:10.1016/j.cger.2018.01.009
  • Hwang CS, Lee HS, Kim SN, Kim JH, Park DJ, Kim KS. Prevalence and risk factors of chronic rhinosinusitis in the elderly population of Korea. Am J Rhinol Allergy. 2019;33(3):240–246. doi:10.1177/1945892418813822
  • Won HK, Kim YC, Kang MG, et al. Age-related prevalence of chronic rhinosinusitis and nasal polyps and their relationships with asthma onset. Ann Allergy Asthma Immunol. 2018;120(4):389–394. doi:10.1016/j.anai.2018.02.005
  • Alt JA, Smith TL. Chronic rhinosinusitis and sleep: a contemporary review. Int Forum Allergy Rhinol. 2013;3(11):941–949. doi:10.1002/alr.21217
  • Soler ZM, Eckert MA, Storck K, Schlosser RJ. Cognitive function in chronic rhinosinusitis: a controlled clinical study. Int Forum Allergy Rhinol. 2015;5(11):1010–1017. doi:10.1002/alr.21581
  • Soler ZM, Wittenberg E, Schlosser RJ, Mace JC, Smith TL. Health state utility values in patients undergoing endoscopic sinus surgery. Laryngoscope. 2011;121(12):2672–2678. doi:10.1002/lary.21847
  • Bhattacharyya N, Villeneuve S, VN J, et al. Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps. Laryngoscope. 2019;129(9):1969–1975. doi:10.1002/lary.27852
  • Jang DW, Lee HJ, Huang RJ, Cheng J, Abi Hachem R, Scales CD. Healthcare resource utilization for chronic rhinosinusitis in older adults. Healthcare. 2021;9:7. doi:10.3390/healthcare9070796
  • Johnson J. Bailey’s Head and Neck Surgery: Otolaryngology. Wolters Kluwer Health; 2013.
  • Wesley Burks A, Holgate ST, O’Hehir RE, et al. Middleton’s Allergy: Principles and Practice. Elsevier; 2019.
  • Johansson L, Akerlund A, Holmberg K, Melén I, Bende M. Prevalence of nasal polyps in adults: the Skövde population-based study. Ann Otol Rhinol Laryngol. 2003;112(7):625–629. doi:10.1177/000348940311200709
  • Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1–464. doi:10.4193/Rhin20.401
  • Cho SH, Hong SJ, Han B, et al. Age-related differences in the pathogenesis of chronic rhinosinusitis. J Allergy Clin Immunol. 2012;129(3):858–860.e2. doi:10.1016/j.jaci.2011.12.002
  • Cho SH, Kim DW, Lee SH, et al. Age-related increased prevalence of asthma and nasal polyps in chronic rhinosinusitis and its association with altered IL-6 trans-signaling. Am J Respir Cell Mol Biol. 2015;53(5):601–606. doi:10.1165/rcmb.2015-0207RC
  • DelGaudio JM, Panella NJ. Presbynasalis. Int Forum Allergy Rhinol. 2016;6(10):1083–1087. doi:10.1002/alr.21787
  • Loftus PA, Wise SK, Nieto D, Panella N, Aiken A, DelGaudio JM. Intranasal volume increases with age: computed tomography volumetric analysis in adults. Laryngoscope. 2016;126(10):2212–2215. doi:10.1002/lary.26064
  • Kalmovich LM, Elad D, Zaretsky U, et al. Endonasal geometry changes in elderly people: acoustic rhinometry measurements. J Gerontol Biol Sci Med Sci. 2005;60(3):396–398. doi:10.1093/gerona/60.3.396
  • Edelstein DR. Aging of the normal nose in adults. Laryngoscope. 1996;106(9 Pt 2):1–25. doi:10.1097/00005537-199609001-00001
  • Mirza N, Kroger H, Doty RL. Influence of age on the “nasal cycle.”. Laryngoscope. 1997;107(1):62–66. doi:10.1097/00005537-199701000-00014
  • Ho JC, Chan KN, Hu WH, et al. The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure of respiratory cilia. Am J Respir Crit Care Med. 2001;163(4):983–988. doi:10.1164/ajrccm.163.4.9909121
  • Proença de Oliveira-maul J, Barbosa de Carvalho H, Goto DM, et al. Aging, diabetes, and hypertension are associated with decreased nasal mucociliary clearance. Chest. 2013;143(4):1091–1097. doi:10.1378/chest.12-1183
  • Bende M. Blood flow with 133Xe in human nasal mucosa in relation to age, sex and body position. Acta Otolaryngol. 1983;96(1–2):175–179. doi:10.3109/00016488309132889
  • Doty RL, Shaman P, Applebaum SL, Giberson R, Siksorski L, Rosenberg L. Smell identification ability: changes with age. Science. 1984;226(4681):1441–1443. doi:10.1126/science.6505700
  • Paik SI, Lehman MN, Seiden AM, Duncan HJ, Smith DV. Human olfactory biopsy. The influence of age and receptor distribution. Arch Otolaryngol Head Neck Surg. 1992;118(7):731–738. doi:10.1001/archotol.1992.01880070061012
  • Santos DV, Reiter ER, DiNardo LJ, Costanzo RM. Hazardous events associated with impaired olfactory function. Arch Otolaryngol Head Neck Surg. 2004;130(3):317–319. doi:10.1001/archotol.130.3.317
  • Renteria AE, Mfuna Endam L, Desrosiers M. Do aging factors influence the clinical presentation and management of chronic rhinosinusitis? Otolaryngol Head Neck Surg. 2017;156(4):598–605. doi:10.1177/0194599817691258
  • Salvioli S, Monti D, Lanzarini C, et al. Immune system, cell senescence, aging and longevity–inflamm-aging reappraised. Curr Pharm Des. 2013;19(9):1675–1679.
  • Song WJ, Lee JH, Won HK, Bachert C. Chronic rhinosinusitis with Nasal polyps in older adults: clinical presentation, pathophysiology, and comorbidity. Curr Allergy Asthma Rep. 2019;19(10):46. doi:10.1007/s11882-019-0880-4
  • Bauer AM, Turner JH. Personalized medicine in chronic rhinosinusitis: phenotypes, endotypes, and biomarkers. Immunol Allergy Clin North Am. 2020;40(2):281–293. doi:10.1016/j.iac.2019.12.007
  • Jiang WX, Cao PP, Li ZY, et al. A retrospective study of changes of histopathology of nasal polyps in adult Chinese in central China. Rhinology. 2019;57(4):261–267. doi:10.4193/Rhin18.070
  • Ramakrishnan VR, Feazel LM, Gitomer SA, Ir D, Robertson CE, Frank DN. The microbiome of the middle meatus in healthy adults. PLoS One. 2013;8(12):e85507. doi:10.1371/journal.pone.0085507
  • Leszczyńska J, Stryjewska-Makuch G, Ścierski W, Lisowska G. Bacterial flora of the nose and paranasal sinuses among patients over 65 years old with chronic rhinosinusitis who underwent endoscopic Sinus Surgery. Clin Interv Aging. 2020;15:207–215. doi:10.2147/CIA.S215917
  • Nomura K, Obata K, Keira T, et al. Pseudomonas aeruginosa elastase causes transient disruption of tight junctions and downregulation of PAR-2 in human nasal epithelial cells. Respir Res. 2014;15:21. doi:10.1186/1465-9921-15-21
  • Grayson JW, Hopkins C, Mori E, Senior B, Harvey RJ. Contemporary classification of chronic rhinosinusitis beyond polyps vs no polyps: a review. JAMA Otolaryngol Head Neck Surg. 2020;146(9):831–838. doi:10.1001/jamaoto.2020.1453
  • Tomassen P, Vandeplas G, Van Zele T, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016;137(5):1449–1456.e4. doi:10.1016/j.jaci.2015.12.1324
  • Kato A. Immunopathology of chronic rhinosinusitis. Allergol Int. 2015;64(2):121–130. doi:10.1016/j.alit.2014.12.006
  • Amirapu S, Biswas K, Radcliff FJ, Wagner Mackenzie B, Ball S, Douglas RG. Sinonasal tissue remodelling during chronic rhinosinusitis. Int J Otolaryngol. 2021;2021:7428955. doi:10.1155/2021/7428955
  • Maniu AA, Perde-Schrepler MI, Tatomir CB, et al. Latest advances in chronic rhinosinusitis with nasal polyps endotyping and biomarkers, and their significance for daily practice. Rom J Morphol Embryol. 2020;61(2):309–320. doi:10.47162/RJME.61.2.01
  • Ikeda K, Shiozawa A, Ono N, et al. Subclassification of chronic rhinosinusitis with nasal polyp based on eosinophil and neutrophil. Laryngoscope. 2013;123(11):E1–E9. doi:10.1002/lary.24154
  • Lou H, Zhang N, Bachert C, Zhang L. Highlights of eosinophilic chronic rhinosinusitis with nasal polyps in definition, prognosis, and advancement. Int Forum Allergy Rhinol. 2018;8(11):1218–1225. doi:10.1002/alr.22214
  • Hu Y, Cao PP, Liang GT, Cui YH, Liu Z. Diagnostic significance of blood eosinophil count in eosinophilic chronic rhinosinusitis with nasal polyps in Chinese adults. Laryngoscope. 2012;122(3):498–503. doi:10.1002/lary.22507
  • Workman AD, Kohanski MA, Cohen NA. Biomarkers in chronic rhinosinusitis with Nasal Polyps. Immunol Allergy Clin North Am. 2018;38(4):679–692. doi:10.1016/j.iac.2018.06.006
  • Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015;152(2 Suppl):S1–S39. doi:10.1177/0194599815572097
  • Bachert C, Pawankar R, Zhang L, et al. ICON: chronic rhinosinusitis. World Allergy Organ J. 2014;7(1):25. doi:10.1186/1939-4551-7-25
  • Busaba NY. The impact of a patient’s age on the clinical presentation of inflammatory paranasal sinus disease. Am J Otolaryngol. 2013;34(5):449–453. doi:10.1016/j.amjoto.2013.03.013
  • Jarvis D, Newson R, Lotvall J, et al. Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe. Allergy. 2012;67(1):91–98. doi:10.1111/j.1398-9995.2011.02709.x
  • Buchheit K, Bensko JC, Lewis E, Gakpo D, Laidlaw TM. The importance of timely diagnosis of aspirin-exacerbated respiratory disease for patient health and safety. World J Otorhinolaryngol Head Neck Surg. 2020;6(4):203–206. doi:10.1016/j.wjorl.2020.07.003
  • Lee-Sarwar K, Johns C, Laidlaw TM, Cahill KN. Tolerance of daily low-dose aspirin does not preclude aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2015;3(3):449–451. doi:10.1016/j.jaip.2015.01.007
  • White AA, Stevenson DD. Aspirin-exacerbated respiratory disease. N Engl J Med. 2018;379(11):1060–1070. doi:10.1056/NEJMra1712125
  • Andersén H, Ilmarinen P, Honkamäki J, et al. NSAID-exacerbated respiratory disease: a population study. ERJ Open Res. 2022;8:1. doi:10.1183/23120541.00462-2021
  • Harvey R, Hannan SA, Badia L, Scadding G, Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev. 2007;3:CD006394. doi:10.1002/14651858.CD006394.pub2
  • LaForce C, Journeay GE, Miller SD, et al. Ocular safety of fluticasone furoate nasal spray in patients with perennial allergic rhinitis: a 2-year study. Ann Allergy Asthma Immunol. 2013;111(1):45–50. doi:10.1016/j.anai.2013.04.013
  • Fromer LM, Ortiz GR, Dowdee AM. Assessment of patient attitudes about mometasone Furoate Nasal Spray: the Ease-of-Use Patient Survey. World Allergy Organ J. 2008;1(9):156–159. doi:10.1097/WOX.0b013e3181865f99
  • Mullol J, Obando A, Pujols L, Alobid I. Corticosteroid treatment in chronic rhinosinusitis: the possibilities and the limits. Immunol Allergy Clin North Am. 2009;29(4):657–668. doi:10.1016/j.iac.2009.07.001
  • Poetker DM, Reh DD. A comprehensive review of the adverse effects of systemic corticosteroids. Otolaryngol Clin North Am. 2010;43(4):753–768. doi:10.1016/j.otc.2010.04.003
  • Paglia F, Dionisi S, De Geronimo S, et al. Biomarkers of bone turnover after a short period of steroid therapy in elderly men. Clin Chem. 2001;47(7):1314–1316. doi:10.1093/clinchem/47.7.1314
  • Van Zele T, Gevaert P, Holtappels G, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol. 2010;125(5):1069–1076.e4. doi:10.1016/j.jaci.2010.02.020
  • Winkel P, Hilden J, Fischer Hansen J, et al. Excess sudden cardiac deaths after short-term clarithromycin administration in the CLARICOR trial: why is this so, and why are statins protective? Cardiology. 2011;118(1):63–67. doi:10.1159/000324533
  • Winkel P, Hilden J, Hansen JF, et al. Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10 years in the CLARICOR randomised, blinded clinical trial. Int J Cardiol. 2015;182:459–465. doi:10.1016/j.ijcard.2015.01.020
  • Gluud C, Als-Nielsen B, Damgaard M, et al. Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart disease. Cardiology. 2008;111(4):280–287. doi:10.1159/000128994
  • Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group Phase 3 trials. Lancet. 2019;394(10209):1638–1650. doi:10.1016/S0140-6736(19)31881-1
  • Han JK, Bachert C, Fokkens W, et al. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021;9(10):1141–1153. doi:10.1016/S2213-2600(21)00097-7
  • Gevaert P, Omachi TA, Corren J, et al. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol. 2020;146(3):595–605. doi:10.1016/j.jaci.2020.05.032
  • Colclasure JC, Gross CW, Kountakis SE. Endoscopic sinus surgery in patients older than sixty. Otolaryngol Head Neck Surg. 2004;131(6):946–949. doi:10.1016/j.otohns.2004.06.710
  • Ramadan HH, VanMetre R. Endoscopic sinus surgery in geriatric population. Am J Rhinol. 2004;18(2):125–127. doi:10.1177/194589240401800210
  • Jiang RS, Hsu CY. Endoscopic sinus surgery for the treatment of chronic sinusitis in geriatric patients. Ear Nose Throat J. 2001;80(4):230–232. doi:10.1177/014556130108000411
  • Krings JG, Kallogjeri D, Wineland A, Nepple KG, Piccirillo JF, Getz AE. Complications of primary and revision functional endoscopic sinus surgery for chronic rhinosinusitis. Laryngoscope. 2014;124(4):838–845. doi:10.1002/lary.24401
  • Gardner JR, Campbell JB, Daigle O, King D, Kanaan A. Operative and postoperative outcomes in elderly patients undergoing endoscopic sinus surgery. Eur Arch Otorhinolaryngol. 2021;278(5):1471–1476. doi:10.1007/s00405-020-06453-2
  • Reh DD, Mace J, Robinson JL, Smith TL. Impact of age on presentation of chronic rhinosinusitis and outcomes of endoscopic sinus surgery. Am J Rhinol. 2007;21(2):207–213. doi:10.2500/ajr.2007.21.3005
  • Lehmann AE, Scangas GA, Sethi RKV, Remenschneider AK, El Rassi E, Metson R. Impact of age on sinus surgery outcomes. Laryngoscope. 2018;128(12):2681–2687. doi:10.1002/lary.27285
  • Helman SN, Carlton D, Deutsch B, et al. Geriatric sinus surgery: a review of demographic variables, surgical success and complications in elderly surgical patients. Allergy Rhinol. 2021;12:21526567211010736. doi:10.1177/21526567211010736
  • Lee JY, Lee SW. Influence of age on the surgical outcome after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis. Laryngoscope. 2007;117(6):1084–1089. doi:10.1097/MLG.0b013e318058197a
  • Shin JM, Byun JY, Baek BJ, Lee JY. Cellular proliferation and angiogenesis in nasal polyps of young adult and geriatric patients. Int Forum Allergy Rhinol. 2015;5(6):541–546. doi:10.1002/alr.21506
  • Brescia G, Barion U, Pedruzzi B, et al. Sinonasal polyposis in the elderly. Am J Rhinol Allergy. 2016;30(5):153–156. doi:10.2500/ajra.2016.30.4349
  • Brescia G, Marioni G, Franchella S, et al. Can a panel of clinical, laboratory, and pathological variables pinpoint patients with sinonasal polyposis at higher risk of recurrence after surgery? Am J Otolaryngol. 2015;36(4):554–558. doi:10.1016/j.amjoto.2015.01.019
  • Kim DW, Kim DK, Jo A, et al. Age-related decline of neutrophilic inflammation is associated with better postoperative prognosis in non-eosinophilic Nasal Polyps. PLoS One. 2016;11(2):e0148442. doi:10.1371/journal.pone.0148442
  • Wen W, Liu W, Zhang L, et al. Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy. J Allergy Clin Immunol. 2012;129(6):1522–1528.e5. doi:10.1016/j.jaci.2012.01.079
  • Brescia G, Marioni G, Franchella S, et al. A prospective investigation of predictive parameters for post-surgical recurrences in sinonasal polyposis. Eur Arch Otorhinolaryngol. 2016;273(3):655–660. doi:10.1007/s00405-015-3598-5
  • Vlaminck S, Vauterin T, Hellings PW, et al. The importance of local eosinophilia in the surgical outcome of chronic rhinosinusitis: a 3-year prospective observational study. Am J Rhinol Allergy. 2014;28(3):260–264. doi:10.2500/ajra.2014.28.4024
  • Min JY, Kim YM, Kim DW, et al. Risk model establishment of endoscopic sinus surgery for patients with chronic rhinosinusitis: a multicenter study in Korea. J Korean Med Sci. 2021;36(40):e264. doi:10.3346/jkms.2021.36.e264
  • Weilbach C, Scheinichen D, Thissen U, Jaeger K, Heine J, Piepenbrock S. [Anaesthesia in cataract surgery for elderly people]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2004;39(5):276–280. German. doi:10.1055/s-2004-814436
  • Wormald PJ, van Renen G, Perks J, Jones JA, Langton-Hewer CD. The effect of the total intravenous anesthesia compared with inhalational anesthesia on the surgical field during endoscopic sinus surgery. Am J Rhinol. 2005;19(5):514–520. doi:10.1177/194589240501900516
  • Rhinology: KA. Sinus surgery in the older patient. Oper Tech Otolaryngol - Head Neck Surg. 2020;31(3):186–191. doi:10.1016/j.otot.2020.07.002
  • Chaaban MR, Baillargeon JG, Baillargeon G, Resto V, Kuo YF. Use of balloon sinuplasty in patients with chronic rhinosinusitis in the United States. Int Forum Allergy Rhinol. 2017;7(6):600–608. doi:10.1002/alr.21939
  • Viera-Artiles J, Corriols-Noval P, López-Simón E, González-Aguado R, Lobo D, Megía R. In-office endoscopic nasal polypectomy: prospective analysis of patient tolerability and efficacy. Eur Arch Otorhinolaryngol. 2020;277(12):3341–3348. doi:10.1007/s00405-020-06196-0
  • Rudmik L, Soler ZM, Mace JC, Schlosser RJ, Smith TL. Economic evaluation of endoscopic sinus surgery versus continued medical therapy for refractory chronic rhinosinusitis. Laryngoscope. 2015;125(1):25–32. doi:10.1002/lary.24916
  • Klimek L, Koennecke M, Mullol J, et al. A possible role of stem cells in nasal polyposis. Allergy. 2017;72(12):1868–1873. doi:10.1111/all.13221
  • Cho KS, Kim YW, Kang MJ, Park HY, Hong SL, Roh HJ. Immunomodulatory effect of mesenchymal stem cells on T lymphocyte and cytokine expression in Nasal Polyps. Otolaryngol Head Neck Surg. 2014;150(6):1062–1070. doi:10.1177/0194599814525751
  • Pezato R, de Almeida DC, Bezerra TF, et al. Immunoregulatory effects of bone marrow-derived mesenchymal stem cells in the Nasal Polyp Microenvironment. Mediators Inflamm. 2014;2014:1–11. doi:10.1155/2014/583409
  • Yang C, Li J, Lin H, Zhao K, Zheng C. Nasal mucosa derived-mesenchymal stem cells from mice reduce inflammation via modulating immune responses. PLoS One. 2015;10(3):e0118849. doi:10.1371/journal.pone.0118849
  • Trombitaș VE, Nagy AA, Berce C, et al. The role of mesenchymal stem cells in the treatment of a chronic rhinosinusitis-An in vivo mouse model. Microorganisms. 2021;9:6. doi:10.3390/microorganisms9061182